COMPARISON OF CITALOPRAM AND METACOGNITIVE THERAPY ON DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KHEIRABADI GHOLAMREZA; YOUSEFIAN ZAHRA; GHASEMI NEZAMADDIN; ZAMANI MAJID; MARACY MOHAMMAD REZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Isfahan Medical School Year:2017 | Volume:35 | Issue:447 Page(s): 1242-1248

Download Full-Text

Persian Verion

View:

1,247

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF CITALOPRAM AND METACOGNITIVE THERAPY ON DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Author(s)

Keywords

CITALOPRAMQ2

METACOGNITIONQ1

EMOTIONQ1

MAJOR DEPRESSIVE DISORDERQ2

Abstract

Background: MAJOR DEPRESSIVE DISORDER (MDD) is a prevalent and devastating psychiatric disorder worldwide that needs multidimensional interventions. Metacognitive treatment is a new psychotherapeutic approach of some psychiatric disorders. This study was conducted to comparatively evaluate the impact of CITALOPRAM and metacognitive interventions on MAJOR DEPRESSIVE DISORDER.Methods: This was a clinical trial study with a pretest/posttest design. After selection of objects, the eligible patients were randomly assigned into three groups of CITALOPRAM (n=12), metacognitive intervention (n=16), and waiting list (n=8). One experimental group received ten 1-houre sessions of metacognitive therapy; 10-40 mg CITALOPRAM was administered to other group; and third group did not receive any interventions and placed on waiting list. Outcome measures were done using Beck Depression Inventory (BDI), METACOGNITIONs Questionnaire-30 (MCQ30), and Cognitive EMOTION Regulation Questionnaire (CERQ) before and after interventions. Data analysis was performed using ANOVA and post hoc tests.Findings: There was significant difference between the groups in terms of symptom of depression, METACOGNITION, and EMOTION regulation before and after intervention. In term of METACOGNITION, only metacognitive therapy was useful (P=0.010). Symptom of depression were improved significantly with metacognitive therapy (P=0.007); but in pharmacotherapy, despite clinical improvement, there was not any statistically significant improvement (P=0.070). In addition, EMOTION regulation was improved with metacognitive therapy (P=0.020).Conclusion: Metacognitive therapy could be used in MAJOR DEPRESSIVE DISORDER. In addition, this intervention could lead to higher level of cognitive EMOTION regulation.

Cites

No record.

References

No record.

Cite

APA: Copy

KHEIRABADI, GHOLAMREZA, YOUSEFIAN, ZAHRA, GHASEMI, NEZAMADDIN, ZAMANI, MAJID, & MARACY, MOHAMMAD REZA. (2017). COMPARISON OF CITALOPRAM AND METACOGNITIVE THERAPY ON DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 35(447 ), 1242-1248. SID. https://sid.ir/paper/49874/en

Vancouver: Copy

KHEIRABADI GHOLAMREZA, YOUSEFIAN ZAHRA, GHASEMI NEZAMADDIN, ZAMANI MAJID, MARACY MOHAMMAD REZA. COMPARISON OF CITALOPRAM AND METACOGNITIVE THERAPY ON DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2017;35(447 ):1242-1248. Available from: https://sid.ir/paper/49874/en

IEEE: Copy

GHOLAMREZA KHEIRABADI, ZAHRA YOUSEFIAN, NEZAMADDIN GHASEMI, MAJID ZAMANI, and MOHAMMAD REZA MARACY, “COMPARISON OF CITALOPRAM AND METACOGNITIVE THERAPY ON DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 35, no. 447 , pp. 1242–1248, 2017, [Online]. Available: https://sid.ir/paper/49874/en

Related Journal Papers